Insider Shareholders with Direct Ownership of Boston Scientific Corp (BSX)
This section provides a comprehensive overview of the insiders with direct ownership of Boston Scientific Corp (BSX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BOSTON SCIENTIFIC CORP Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Michael F Mahoney
Chairman, President & CEO |
3,313,057 | 3,845,631 | 1,653,354 $167 Million | 97 |
Feb 17, 2025
Reduced 0.53%
|
Daniel J. Brennan
EVP and CFO |
570,076 | 607,511 | 225,808 $22.7 Million | 84 |
Feb 19, 2025
Reduced 22.97%
|
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology |
646,795 | 689,726 | 180,382 $18.2 Million | 90 |
Feb 20, 2025
Reduced 0.55%
|
Maulik Nanavaty
SVP & Pres, Neuromodulation |
40,057 | 92,500 | 177,258 $17.9 Million | 27 |
Feb 28, 2022
Reduced 0.32%
|
David J Roux
Director |
13,586 | 0 | 73,591 $7.41 Million | 3 |
May 04, 2023
Added 5.09%
|
Edward F Mackey
EVP, Operations |
86,710 | 99,475 | 52,944 $5.33 Million | 27 |
Feb 28, 2022
Reduced 2.01%
|
John E Sununu
Director |
16,487 | 0 | 52,642 $5.3 Million | 4 |
May 09, 2024
Added 5.22%
|
Vance R Brown
SVP, GC and Corp. Secretary |
94,404 | 75,995 | 45,845 $4.62 Million | 56 |
Feb 21, 2025
Reduced 9.52%
|
David S Wichmann
Director |
39,501 | 0 | 39,501 $3.98 Million | 5 |
May 09, 2024
Added 6.84%
|
Jonathan Monson
SVP, Global Controller and CAO |
42,724 | 39,122 | 37,982 $3.83 Million | 57 |
Feb 18, 2024
Reduced 0.67%
|
Ellen M Zane
Director |
16,487 | 13,586 | 34,944 $3.52 Million | 5 |
Feb 24, 2025
Reduced 28.0%
|
Eric Francis Yves Thepaut
EVP & Pres, Eur, Mid-East, Afr |
199,177 | 260,929 | 31,421 $3.16 Million | 60 |
May 10, 2024
Reduced 29.16%
|
Desiree Ralls Morrison
SVP, GC and Corp Secretary |
26,452 | 7,993 | 29,909 $3.01 Million | 12 |
Feb 21, 2021
Reduced 1.28%
|
Wendy Carruthers
EVP, Human Resources |
204,807 | 354,472 | 29,308 $2.95 Million | 114 |
Dec 02, 2024
Reduced 19.24%
|
Ian T Meredith
EVP Global Chief Med Officer |
30,356 | 22,927 | 28,082 $2.83 Million | 30 |
Mar 28, 2022
Reduced 19.0%
|
Jeffrey B. Mirviss
EVP&Pres, Periph Intervent |
399,575 | 507,511 | 25,766 $2.6 Million | 113 |
Feb 25, 2025
Reduced 9.45%
|
Meghan Scanlon
SVP,Pres,Urology Pelvic Health |
46,053 | 35,120 | 24,461 $2.46 Million | 30 |
May 01, 2022
Reduced 2.42%
|
Edward J Ludwig
Director |
24,596 | 36,695 | 24,398 $2.46 Million | 8 |
Feb 11, 2025
Reduced 32.97%
|
Jodi Euerle Eddy
SVP, Chief Info & Digital Off. |
37,753 | 25,495 | 23,263 $2.34 Million | 35 |
Apr 01, 2022
Reduced 10.67%
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
233,517 | 243,448 | 22,235 $2.24 Million | 94 |
Feb 17, 2025
Reduced 5.58%
|
John Bradley Sorenson
EVP, Global Operations |
145,516 | 162,696 | 20,991 $2.11 Million | 83 |
Feb 19, 2025
Reduced 13.6%
|
Scott Olson
SVP & Pres, CRM, Diagnostics |
14,362 | 11,591 | 14,518 $1.46 Million | 27 |
Apr 01, 2022
Reduced 4.6%
|
Nelda J Connors
Director |
14,921 | 16,088 | 8,823 $888,652 | 4 |
May 04, 2023
Added 30.9%
|
Stephen P Macmillan
Director |
498 | 0 | 8,000 $805,760 | 1 |
Oct 01, 2020
Added 5.86%
|
Jessica L Mega
Director |
6,154 | 0 | 6,154 $619,830 | 2 |
May 09, 2024
Added 32.04%
|
Emily Woodworth
SVP, Global Controller and CAO |
2,444 | 2,436 | 4,301 $433,196 | 9 |
Feb 17, 2025
Reduced 6.17%
|
Susan E Morano
Director |
3,953 | 0 | 3,953 $398,146 | 2 |
May 09, 2024
Added 9.63%
|
David C Habiger
Director |
3,407 | 0 | 3,547 $357,253 | 1 |
Aug 01, 2024
Added 26.09%
|
Charles J Dockendorff
Director |
18,926 | 21,025 | 2,901 $292,188 | 6 |
May 09, 2024
Added 50.0%
|
Yoshiaki Fujimori
Director |
2,901 | 0 | 2,901 $292,188 | 1 |
May 09, 2024
Added 50.0%
|
David A Pierce
EVP Pres MedSurg |
113,686 | 120,053 | 0 $0 | 44 |
Mar 01, 2022
Reduced 100.0%
|
Miriam O'Sullivan
SVP, Chief HR Officer |
4,074 | 1,253 | 0 $0 | 8 |
N/A
|